Vijyoti Medical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -23.87%
(FY 2023)
- Profit -6.91%
(FY 2023)
- Ebitda -8.02%
(FY 2023)
- Net Worth 65.54%
(FY 2023)
- Total Assets -13.66%
(FY 2023)
About Vijyoti Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Pande, Anupam Ahuja, and Nirupam Pande serve as directors at the Company.
- CIN/LLPIN
U51909DL2019PTC354646
- Company No.
354646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2019
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vijyoti Medical Private Limited offer?
Vijyoti Medical Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Cardiovascular Drugs & Medication, Cholesterol Medicine, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Vijyoti Medical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Pande  | Director | 03-Sep-2019 | Current |
| Anupam Ahuja | Director | 03-Sep-2019 | Current |
| Nirupam Pande | Director | 03-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Vijyoti Medical.
Vijyoti Medical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.87% decrease. The company also saw a slight decrease in profitability, with a 6.91% decrease in profit. The company's net worth Soared by an impressive increase of 65.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vijyoti Medical?
In 2023, Vijyoti Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vijyoti Management & Communications Learning Institute Private LimitedActive 17 years 3 monthsVijay Pande, Anupam Ahuja and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vijyoti Medical?
Unlock and access historical data on people associated with Vijyoti Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vijyoti Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vijyoti Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
